PERRIGO Co plc
PRGO · XNYSCIK 1585364fmd_0H6K85X2EKSP8SWWKBPWCH9J81Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jun 26, 2011 to Sep 26, 2026, 58 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 5,281 | 4,946 | 4,732 | 3,870 | 4,088 | 4,139 | 4,452 | 4,656 | 4,373 | 4,253 |
| Cost of revenue | 3,229 | 2,967 | 2,900 | 2,436 | 2,593 | 2,723 | 2,996 | 2,975 | 2,831 | 2,759 |
| Net interest income | (217) | (168) | (128) | (118) | (128) | (125) | (156) | (174) | – | – |
| Gross profit | 2,052 | 1,980 | 1,832 | 1,434 | 1,495 | 1,416 | 1,455 | 1,680 | 1,543 | 1,495 |
| Research and development | 184 | 168 | 219 | 119 | 122 | 122 | 123 | 123 | 112 | 95 |
| Selling, general and administrative | 1,117 | 1,060 | 1,032 | 1,015 | 1,024 | 1,018 | 1,097 | 1,164 | 1,015 | 962 |
| Total operating expenses | 4,052 | 1,381 | 1,595 | 1,259 | 1,230 | 1,006 | 1,377 | 1,529 | 1,430 | 2,617 |
| Operating income | (2,000) | 598 | 237 | 175 | 265 | 410 | 79 | 152 | 113 | (1,122) |
| Other non-operating income (expense) | (23) | 10 | (6) | 69 | (16) | (27) | (53) | 10 | 1 | (13) |
| Income before taxes | (4,848) | 280 | 291 | 516 | (86) | 259 | (139) | (8) | (81) | (1,298) |
| Income tax expense | (836) | 161 | 160 | (11) | (38) | 390 | (8) | (4) | 80 | 104 |
| Net income from continuing operations | (4,013) | 120 | 131 | 159 | 44 | (131) | (131) | (4) | (161) | (1,402) |
| Net income | (4,013) | 120 | 131 | 146 | (163) | (69) | (141) | (13) | (172) | (1,425) |